Abstract
Purpose
To investigate the effect of detrusor underactivity on the efficacy of TURP in patients with benign prostate obstruction.
Methods
A retrospective study of 350 patients with benign prostate obstruction who underwent TURP was carried out. Different degrees of bladder outlet obstruction were grouped by the bladder outlet obstruction index. ROC curves were used to calculate the optimal cut-off point for the bladder contractility index used to divide the DU patients into mild DU and severe DU patients. The effect of DU on the efficacy of TURP in benign prostate obstruction patients was studied by comparing the subjective and objective parameters preoperatively and 3 months postoperatively between severe DU, mild DU and non-DU benign prostate obstruction patients in two obstruction groups (20 ≤ BOOI < 40 and BOOI ≥ 40).
Results
According to the ROC curve, the optimal cut-off point for the bladder contractility index was 82; thus, 69 patients were considered mild DU patients (82 ≤ BCI < 100), 67 patients were considered severe DU patients (BCI < 82), and 214 patients were considered non-DU patients (BCI ≥ 100). Both the postoperative subjective and objective parameters of the non-DU, mild DU and severe DU patients significantly improved in two obstruction groups. However, in the 20 ≤ BOOI < 40 group, the successful improvement rates for the IPSS, IPSS-S, IPSS-V, QoL and fQmax in the severe DU patients were only 38.2%, 38.2%, 44.1%, 41.2% and 38.2%, respectively.
Conclusion
Patients with varying degrees of benign prostate obstruction can benefit from TURP, but for patients with severe DU in the 20 ≤ BOOI < 40 group, TURP should be considered only after deliberation.
Similar content being viewed by others
Availability of data and material
All authors make sure that all data and materials support the published claims and comply with field standards.
Code availability
All authors make sure that software application or custom code support the published claims and comply with field standards.
References
Gratzke C, Bachmann A, Descazeaud A et al (2015) EAU guidelines on the assessment of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol 67(6):1099–1109
Sarma AV, Wei JT (2012) Clinical practice. Benign prostatic hyperplasia and lower urinary tract symptoms. N Engl J Med 367:248–257
Rassweiler J, Teber D, Kuntz R, Hofmann R (2006) Complications of transurethral resection of the prostate (TURP)–incidence, management, and prevention. Eur Urol 50:969–979 (discussion 980)
Kanik EA, Erdem E, Abidinoglu D, Acar D, Akbay E, Ulusoy E (2004) Can the outcome of transurethral resection of the prostate be predicted preoperatively. Urology 64:302–305
Thomas AW, Cannon A, Bartlett E, Ellis-Jones J, Abrams P (2005) The natural history of lower urinary tract dysfunction in men: minimum 10-year urodynamic follow-up of untreated bladder outlet obstruction. BJU Int 96:1301–1306
Chapple CR, Osman NI, Birder L, Dmochowski R, Drake MJ, van Koeveringe G et al (2018) Terminology report from the international continence society (ICS) working group on underactive bladder (UAB). Neurourol Urodyn 37:2928–2931
Li X, Liao L (2016) Updates of underactive bladder: a review of the recent literature. Int Urol Nephrol 48:919–930
Osman NI, Esperto F, Chapple CR (2018) Detrusor underactivity and the underactive bladder: a systematic review of preclinical and clinical studies. Eur Urol 74:633–643
Abrams P (1999) Bladder outlet obstruction index, bladder contractility index and bladder voiding efficiency: three simple indices to define bladder voiding function. BJU Int 84:14–15
Lee KH, Kuo HC (2019) Recovery of voiding efficiency and bladder function in male patients with non-neurogenic detrusor underactivity after transurethral bladder outlet surgery. Urology 123:235–241
Rademakers KL, van Koeveringe GA, Oelke M (2016) Detrusor underactivity in men with lower urinary tract symptoms/benign prostatic obstruction: characterization and potential impact on indications for surgical treatment of the prostate. Curr Opin Urol 26:3–10
Homma Y, Kawabe K, Tsukamoto T et al (1996) Estimate criteria for efficacy of treatment in benign prostatic hyperplasia. Int J Urol 3(4):267–273
van der Wijden FC, de Angst IB, Lamers R, Cuypers M, de Vries M, van Melick H et al (2018) Effectiveness of a web-based treatment decision aid for men with lower urinary tract symptoms due to benign prostatic hyperplasia. BJU Int 124:124–133
Oh MM, Kim JW, Kim JJ, du Moon G (2012) Is there a correlation between the outcome of transurethral resection of prostate and preoperative degree of bladder outlet obstruction. Asian J Androl 14:556–559
Hoag N, Gani J (2015) Underactive bladder: clinical features, urodynamic parameters, and treatment. Int Neurourol J 19:185–189
Chang YH, Siu JJ, Hsiao PJ, Chang CH, Chou EC (2018) Review of underactive bladder. J Formos Med Assoc 117:178–184
Aldamanhori R, Osman NI, Chapple CR (2018) Underactive bladder: pathophysiology and clinical significance. Asian J Urol 5:17–21
Donkelaar SCT, Rosier P, de Kort L (2017) Comparison of three methods to analyze detrusor contraction during micturition in men over 50 years of age. Neurourol Urodyn 36:2153–2159
Yu Z, Li J, Li Z, Hou R (2015) Photoselective vaporization of the prostate and simultaneous suprapubic cystostomy for the treatment of benign prostatic hyperplasia in patients with mild to severe detrusor underactivity. Urol Int 95:269–275
Griffiths DJ (1991) Assessment of detrusor contraction strength or contractility. Neurourol Urodyn 10:1–18
Lee SM, Hashim H (2018) Recent advances in the understanding and management of underactive bladder. F1000Res 7:437
Acknowledgements
Thanks all related hospital staff and patients involved in the study.
Funding
There is not related project funding for this topic.
Author information
Authors and Affiliations
Contributions
Y.Z.: Conception and design, acquisition of data, analysis and interpretation of data, drafting of the manuscript, critical revision of the manuscript for important intellectual content and statistical analysis; Y.R.Z.: Conception and design, analysis and interpretation of data, critical revision of the manuscript for important intellectual content, administrative, technical or material support and supervision; P.Z.: Conception and design, acquisition of data and analysis and interpretation of data; B.M.Q.: Critical revision of the manuscript for important intellectual content, administrative, technical or material support and supervision; Z.Q.Y.: Acquisition of data, administrative, technical or material support; Y.J.N.: Acquisition of data, administrative, technical or material support; All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflicts of interest
The authors have no relevant financial or non-financial interests to disclose.
Ethics approval
This is an observational study. The Research Ethics Committee has confirmed that no ethical approval is required.
Consent to participate
Verbal informed consent was obtained prior to the interview.
Consent for publication
Patients consent regarding publishing their data.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Zhu, Y., Zhao, YR., Zhong, P. et al. Detrusor underactivity influences the efficacy of TURP in patients with BPO. Int Urol Nephrol 53, 835–841 (2021). https://doi.org/10.1007/s11255-020-02750-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-020-02750-1